middle.news
Cleo Diagnostics Boosts Cash by $1.7M Ahead of US FDA Milestone
8:34am on Wednesday 26th of November, 2025 AEDT
•
Healthcare
Read Story
Cleo Diagnostics Boosts Cash by $1.7M Ahead of US FDA Milestone
8:34am on Wednesday 26th of November, 2025 AEDT
Key Points
Received $1.7 million Australian Government R&D tax incentive refund
Cash balance now approximately $5.75 million
Funding supports completion of US pivotal clinical trial
FDA submission for Pre-Surgical Ovarian Cancer Test planned next year
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Cleo Diagnostics (ASX:COV)
OPEN ARTICLE